Crinetics Pharmaceuticals (CRNX) Cash from Investing Activities (QoQ) (2017 - 2026)
Crinetics Pharmaceuticals (CRNX) Cash from Investing Activities (QoQ) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | Crinetics Pharmaceuticals | 8.73 Bn | 7.44 Bn | 10.53 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -541.91% |
| Dec 31, 2025 | -65.35% |
| Sep 30, 2025 | 334.24% |
| Jun 30, 2025 | 144.15% |
| Mar 31, 2025 | 84.14% |
| Dec 31, 2024 | -2,731.11% |
| Sep 30, 2024 | 138.41% |
| Jun 30, 2024 | -17,459.55% |
| Mar 31, 2024 | 100.35% |
| Dec 31, 2023 | 54.83% |
| Sep 30, 2023 | -714.89% |
| Jun 30, 2023 | -35.52% |
| Mar 31, 2023 | 32.30% |
| Dec 31, 2022 | 440.21% |
| Sep 30, 2022 | 103.91% |
| Jun 30, 2022 | -301.69% |
| Mar 31, 2022 | 57.38% |
| Dec 31, 2021 | -1,349.08% |
| Sep 30, 2021 | -135.41% |
| Jun 30, 2021 | -38.96% |